ClassID:

169331

G01N33/6893 - page 7 - CPC Classification

Classification description:

Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Recent Application in this class:
#1801
20200061217
2020-02-27

Nanoparticle probes and methods of making and use thereof

#1802
20200058404
2020-02-20

INTERACTIVE COMPUTING SYSTEM TO GENERATE CUSTOMIZED PREVENTIVE HEALTH INFORMATION BASED ON AN INDIVIDUAL'S BIOMARKERS

#1803
20200057077
2020-02-20

METHODS FOR QUANTIFYING INTER-ALPHA INHIBITOR PROTEINS

#1804
20200057076
2020-02-20

Methods of treating patients at risk for renal injury and renal failure

#1805
20200057075
2020-02-20

SEROLOGIC ASSAY FOR SILENT BRAIN ISCHEMIA

#1806
20200055929
2020-02-20

Anti-transthyretin antibodies

#1807
20200055899
2020-02-20

PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS

#1808
20200055898
2020-02-20

Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers

#1809
20200049719
2020-02-13

Markers for renal disease

#1810
20200049718
2020-02-13

Methods for in vitro investigating mitochondrial replication dysfunction in a biological sample, kits and uses thereof, therapeutic methods against progeroid-like syndromes or symptoms and screening method for identifying particular protease inhibitor(s) and/or nitroso-redox stress scavenger compound(s)

#1811
20200048317
2020-02-13

Human tear lipocalin muteins which specifically bind lymphocyte activation gene-3 (LAG3) and method of use thereof to stimulate an immune response

#1812
20200041527
2020-02-06

Neurofibromin/dopamine signaling as a biomarker for cognitive and behavioral problems in children with neurofibromatosis type 1 (NF1 )

#1813
20200041526
2020-02-06

Antibodies and methods for the detection of cell death

#1814
20200041525
2020-02-06

DIAGNOSTIC METHODS FOR LIVER DISORDERS

#1815
20200041512
2020-02-06

HLA G-modified cells and methods

#1816
20200033367
2020-01-30

GALECTIN-3 IMMUNOASSAY

#1817
20200033366
2020-01-30

SYSTEMS AND METHODS FOR METABOLOME ANALYSIS

#1818
20200033343
2020-01-30

Exosome-mediated diagnosis of human immunodeficiency virus infection

#1819
20200025776
2020-01-23

Sustained Response Predictors After Treatment With Anti-IL23 Specific Antibody

#1820
20200025775
2020-01-23

USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS

#1821
20200025669
2020-01-23

METHODS AND DEVICES FOR MULTI-STEP CELL PURIFICATION AND CONCENTRATION

#1822
20200018753
2020-01-16

NON-INVASIVE BIOMARKER TO IDENTIFY SUBJECT AT RISK OF PRETERM DELIVERY

#1823
20200018749
2020-01-16

PLUG-IN EXPERTISE FOR PATHOGEN IDENTIFICATION USING MODULAR NEURAL NETWORKS

#1824
20200017914
2020-01-16

Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers

#1825
20200017860
2020-01-16

Therapeutic agents

#1826
20200017597
2020-01-16

Treatment of multiple sclerosis and neuromyelitis optica

#1827
20200011882
2020-01-09

METHOD FOR CALCULATING GLOMERULAR FILTRATION RATE (GFR)

#1828
20200011880
2020-01-09

Identification and analysis of protein biomarkers

#1829
20200011879
2020-01-09

Method of diagnosis of drug induced liver injury

#1830
20200011869
2020-01-09

NON-INVASIVE DIAGNOSIS OF FIBROTIC NON-ALCOHOLIC STEATOHEPATITIS

#1831
20200011866
2020-01-09

Biodosimetry panels and methods

#1832
20200010526
2020-01-09

NEUROPILIN-1 SPECIFIC BINDING PEPTIDE, FUSION PROTEIN FUSED WITH SAME, AND USE THEREOF

#1833
20200009134
2020-01-09

Method and Compound for Modifying Circadian Clock

#1834
20200009106
2020-01-09

Treatment of circadian rhythm disorders

#1835
20200003788
2020-01-02

Exosomal Protein Profiling for Detection of Cardiac Transplant Rejection

#1836
20200003787
2020-01-02

Method for Using a Marker Set for Determining the Risk of Kidney Rejection

#1837
20200003779
2020-01-02

METHOD AND DEVICE FOR DETECTING SIGLEC12

#1838
20200002706
2020-01-02

Cytotoxic T cell response modifiers

#1839
20200002409
2020-01-02

Compositions and methods for the removal of biofilms

#1840
20200002367
2020-01-02

Fluorogenic glycosidase substrate and associated detection method

#1841
20190391164
2019-12-26

QUANTITATIVE METHODS AND KITS FOR PROVIDING REPRODUCIBLE IHC4 SCORES

#1842
20190391163
2019-12-26

Tissue-specific exosomes as biomarkers

#1843
20190391162
2019-12-26

Methods for treating or predicting risk of a ventricular tachyarrhythmia event

#1844
20190391131
2019-12-26

BLOOD BASED BIOMARKERS FOR DIAGNOSING ATHEROSCLEROTIC CORONARY ARTERY DISEASE

#1845
20190390276
2019-12-26

Biomarkers for the diagnosis of lacunar stroke

#1846
20190383831
2019-12-19

DIAGNOSTIC METHOD

#1847
20190383811
2019-12-19

Immunochromatographic device, immunochromatographic kit and immunochromatographic detection method

#1848
20190382842
2019-12-19

DETECTION AND TREATMENT OF DILATED CARDIOMYOPATHY IN THE DOBERMAN PINSCHER

#1849
20190382483
2019-12-19

NEW USES OF ANTI-SIRPg ANTIBODIES

#1850
20190381130
2019-12-19

Methods and compositions for diagnosis and prognosis of renal injury and renal failure

#1851
20190376985
2019-12-12

ADRENOMEDULLIN FOR ASSESSING CONGESTION IN A SUBJECT WITH ACUTE HEART FAILURE

#1852
20190376983
2019-12-12

Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers

#1853
20190376967
2019-12-12

Methods, devices, kits and compositions for detecting roundworm, whipworm and hookworm

#1854
20190376880
2019-12-12

Method of diluting a metred quantity of a test fluid for analysis

#1855
20190375842
2019-12-12

CHECK POINT INHIBITION IN ORGAN FIBROSIS

#1856
20190375776
2019-12-12

IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS

#1857
20190374439
2019-12-12

Kit and method for detecting porous dental hydroxyapatite

#1858
20190369123
2019-12-05

ACPA-NEGATIVE RA DIAGNOSTIC MARKER AND APPLICATION THEREOF

#1859
20190369122
2019-12-05

METABOLIC DISORDERS

#1860
20190369121
2019-12-05

System and method for detection of trauma

#1861
20190369120
2019-12-05

Diagnostic and prognostic methods for cardiovascular diseases and events

#1862
20190369026
2019-12-05

Point-of-care system and method for diagnosing acute febrile illness

#1863
20190367602
2019-12-05

NOVEL MONOCLONAL ANTIBODIES TO OSTEOPONTIN

#1864
20190367584
2019-12-05

Compositions and methods for treating lysosomal storage diseases and disorders

#1865
20190365708
2019-12-05

Vreceptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level

#1866
20190364859
2019-12-05

Preventive or therapeutic agent for kidney disease

#1867
20190361036
2019-11-28

Metabolite biomarkers for diseases associated with the contact activation system

#1868
20190361019
2019-11-28

ACPA-NEGATIVE RA DIAGNOSTIC MARKER AND APPLICATION THEREOF

#1869
20190359703
2019-11-28

Biomarkers for anti-IL4-IL13 bispecific antibodies

#1870
20190359660
2019-11-28

Peptides And Methods For Detecting Peanut Allergies

#1871
20190353667
2019-11-21

Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure

#1872
20190353666
2019-11-21

Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fibrillation

#1873
20190352415
2019-11-21

USE OF THE CD71 RECEPTOR IN THE PROGNOSIS AND TREATMENT OF ENDOMETRIOSIS

#1874
20190350934
2019-11-21

Compositions and methods for treating chemosensory dysfunction

#1875
20190346460
2019-11-14

MASS SPECTROMETRIC STANDARDS FOR HEMOGLOBIN BETA AND HEMOGLOBIN BETA SICKLE AND USES THEREOF

#1876
20190346458
2019-11-14

GFAP ACCUMULATING IN STROKE

#1877
20190346457
2019-11-14

ASSAYS AND METHODS FOR DETECTION AND TARGETED TREATMENT OF HYDROSALPINX

#1878
20190346443
2019-11-14

Exosome-mediated diagnosis of hepatitis virus infections and diseases

#1879
20190346421
2019-11-14

PREDICTION OF KIDNEY DISEASE PROGRESSION USING HOMOARGININE AS A BIOMARKER

#1880
20190346400
2019-11-14

REDOX PROBING FOR CHEMICAL INFORMATION

#1881
20190345557
2019-11-14

ATRIAL FIBRILLATION POLYGENIC RISK SCORE

#1882
20190345555
2019-11-14

Method for detecting the risk and prognosis of adult-onset Still's disease

#1883
20190339290
2019-11-07

Methods and materials for identifying and treating acute graft-versus-host disease

#1884
20190339289
2019-11-07

Methods and compositions for evaluation and treatment of renal injury and renal failure based on C—C motif chemokine ligand 14 measurement

#1885
20190339288
2019-11-07

Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers

#1886
20190338361
2019-11-07

Inhibiting the onset of gout

#1887
20190331698
2019-10-31

MOLECULAR MARKER AND KIT FOR EARLY DIAGNOSIS AND PREDICTION OF SEPSIS ACUTE KIDNEY INJURY AND APPLICATION THEREOF

#1888
20190331697
2019-10-31

Biomarkers for graft-versus-host disease

#1889
20190330297
2019-10-31

INSULIN GENE-DERIVED PROTEINS AND PEPTIDES FOR USE IN THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES

#1890
20190330274
2019-10-31

PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS

#1891
20190324036
2019-10-24

Testing and representing suspicion of sepsis

#1892
20190324035
2019-10-24

Sepsis infection determination systems and methods

#1893
20190317110
2019-10-17

Health test for a broad spectrum of health problems

#1894
20190317109
2019-10-17

Thyroglobulin quantitation by mass spectrometry

#1895
20190317092
2019-10-17

Fab-linked glycans as biomarker for the transition from a pre-disease “at-risk-phase” to rheumatoid arthritis; AAV or Sjögren syndrome

#1896
20190317089
2019-10-17

Multi-array impedimetric biosensors for the detection of concussion and traumatic brain injuries

#1897
20190317083
2019-10-17

Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy

#1898
20190316084
2019-10-17

ANALYSIS AND SORTING OF MOTILE CELLS

#1899
20190315871
2019-10-17

Methods of treating inflammatory and autoimmune diseases with natalizumab

#1900
20190315845
2019-10-17

HUMANIZED ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF

#1901
20190315844
2019-10-17

Anti-GP73 monoclonal antibodies and methods of obtaining the same

#1902
20190314351
2019-10-17

PIRFENIDONE TREATMENT FOR PATIENTS WITH ATYPICAL LIVER FUNCTION

#1903
20190310266
2019-10-10

USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS

#1904
20190310257
2019-10-10

METHOD FOR DISCRIMINATING BETWEEN PROSTATE CANCER AND A BENIGN PROSTATE DISEASE

#1905
20190310255
2019-10-10

PROTEINS

#1906
20190310253
2019-10-10

METHOD FOR DIAGNOSING COMPLICATED PARAPNEUMONIC EFFUSION

#1907
20190310249
2019-10-10

Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis

#1908
20190309368
2019-10-10

Methods and kits for determining predisposition to develop kidney diseases

#1909
20190309054
2019-10-10

NON-POLYAMINATED LCN2 AS A BIOMARKER FOR DIAGNOSIS AND TREATMENT OF CARDIOMETABOLIC DISEASES

#1910
20190302126
2019-10-03

FARBER DISEASE MARKERS AND USES THEREOF

#1911
20190302101
2019-10-03

Use of leucine-zipper protein for diagnosis or treatment of fatty liver

#1912
20190302028
2019-10-03

Method for Measuring Tear Constituents in a Tear Sample

#1913
20190300959
2019-10-03

Biomarkers for use in prognosis of mortality in critically ill patients

#1914
20190300537
2019-10-03

Compounds, compositions and methods

#1915
20190298804
2019-10-03

ACTIVATION OF THE ENDOGENOUS ILEAL BRAKE HORMONE PATHWAY FOR ORGAN REGENERATION AND RELATED COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS, AND REGULATORY SYSTEMS

#1916
20190293662
2019-09-26

GFAP DERIVATIVES FOR STROKE DIAGNOSTICS

#1917
20190293661
2019-09-26

METHOD OF PREDICTING RESPONSIVENESS OF WET AMD PATIENT TO ANTI-VEGF THERAPY

#1918
20190293644
2019-09-26

Compositions and methods for diagnosing and differentiating systemic juvenile idiopathic arthritis and Kawasaki disease

#1919
20190293631
2019-09-26

Treatment methods having reduced drug-related toxicity and methods of identifying the likelihood of patient harm from prescribed medications

#1920
20190285656
2019-09-19

Diabetes-related biomarkers and treatment of diabetes-related conditions

#1921
20190285649
2019-09-19

Biomarker Panel to Identify Patients at Risk for Peri-Implant Osteolysis

#1922
20190285648
2019-09-19

NOVEL LIVER CIRRHOSIS OR LIVER FIBROSIS MARKER

#1923
20190285640
2019-09-19

GROWTH HORMONE RECEPTOR DEFICIENCY CAUSES A MAJOR REDUCTION IN PRO-AGING SIGNALING, CANCER AND DIABETES IN HUMANS

#1924
20190285631
2019-09-19

Methods for diagnosing and treating eosinophilic esophagitis

#1925
20190284302
2019-09-19

Human anti-SOD1 antibodies

#1926
20190277861
2019-09-12

IGFBP7 for diagnosing diastolic dysfunction

#1927
20190277860
2019-09-12

Method of detecting arteriosclerosis

#1928
20190277859
2019-09-12

Biomarker SBP1 for early diagnosis of kidney diseases, and use thereof

#1929
20190276889
2019-09-12

Systems and methods for characterizing sepsis

#1930
20190275032
2019-09-12

USE OF ECM BIOMARKERS FOR DETERMINING THE TREATMENT ONSET WITH NINTEDANIB AND PIRFENIDONE

#1931
20190271709
2019-09-05

Methods of prognosis and treatment

#1932
20190271708
2019-09-05

BLOOD SAMPLE ANALYSIS METHOD AND SYSTEM, FOR DETERMINING DIABETES

#1933
20190271698
2019-09-05

Squalene epoxidase in the diagnosis and treatment of non-alcoholic fatty liver diseases

#1934
20190271042
2019-09-05

Identification of unique gene expression profiles in children with regressive autism spectrum disorder (ASD) and Ileocolitis

#1935
20190265253
2019-08-29

Methods and compositions for diagnosis and prognosis of renal injury and renal failure

#1936
20190265248
2019-08-29

BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS

#1937
20190264285
2019-08-29

POLYMORPHISMS FOR PREDICTING TREATMENT RESPONSE TO ANTIPSYCHOTIC DRUGS AND IDENFYING NEW DRUG TARGETS

#1938
20190262476
2019-08-29

METHOD FOR MEASUREMENT AND CONTROL OF INTRACULAR VEGF CONCENTRATION

#1939
20190262348
2019-08-29

3-(4-((4-morpholinomethyl-benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus

#1940
20190262316
2019-08-29

2-iminobiotin for use in the treatment of brain cell injury

#1941
20190259467
2019-08-22

Method of predicting graft versus host disease

#1942
20190257841
2019-08-22

USE OF sCD14 OR ITS FRAGMENTS OR DERIVATIVES FOR RISK STRATIFICATION, DIAGNOSIS AND PROGNOSIS

#1943
20190257840
2019-08-22

Detection of glucuronidated and 3-bromotyrosine

#1944
20190255149
2019-08-22

Methods for treating sarcopenia and muscle injury

#1945
20190255143
2019-08-22

Therapeutic targets involved in the progression of nonalcoholic steatohepatitis (NASH)

#1946
20190255084
2019-08-22

Diagnostics and methods for treatment of non-alcoholic hepatic steatosis and hepatic steatohepatitis, and prevention of complications thereof

#1947
20190250170
2019-08-15

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE

#1948
20190250147
2019-08-15

METHODS FOR USING ENRICHED EXOSOMES AS A PLATFORM FOR MONITORING ORGAN STATUS

#1949
20190249224
2019-08-15

Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition

#1950
20190248890
2019-08-15

Anti-FcRn antibodies

#1951
20190242908
2019-08-08

METHODS FOR DIAGNOSING AND TREATING NEPHROTIC SYNDROME

#1952
20190242907
2019-08-08

Serologic assay of liver fibrosis

#1953
20190242906
2019-08-08

Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (TBI), using glial fibrillary acidic protein (GFAP) and/or ubiquitin carboxy-terminal hydrolase L1 (UCH-L1)

#1954
20190242895
2019-08-08

Early diagnosis of infections

#1955
20190242886
2019-08-08

COMPOSITIONS, DEVICES, AND METHODS OF GASTROESOPHAGEAL REFLUX DISEASE SENSITIVITY TESTING

#1956
20190241931
2019-08-08

Assay to measure factor Xa inhibitors

#1957
20190234965
2019-08-01

METHOD FOR DETERMINING RISKS ASSOCIATED WITH CARDIOVASCULAR DISEASES

#1958
20190234917
2019-08-01

Trimethylamine-containing compounds for diagnosis and prediction of disease

#1959
20190233893
2019-08-01

Methods of diagnosing endometriosis

#1960
20190233892
2019-08-01

Biomarkers For Endometriosis

#1961
20190227081
2019-07-25

Procalcitonin for the prognosis of adverse events

#1962
20190227080
2019-07-25

Protein activity modification

#1963
20190227058
2019-07-25

Protein Damage in Aging and Age-Related Diseases

#1964
20190226026
2019-07-25

Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof

#1965
20190224135
2019-07-25

Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease

#1966
20190219598
2019-07-18

Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1

#1967
20190219597
2019-07-18

IN VITRO METHOD FOR DIAGNOSING AT EARLY STAGE INTESTINAL ISCHEMIA

#1968
20190219596
2019-07-18

Method for the diagnosis of acute pancreatitis (AP) by detection of glycoprotein 2 isoform alpha (GP2A)

#1969
20190219581
2019-07-18

METHOD FOR PREDICTING THE RESPONSE TO HER2-DIRECTED THERAPY

#1970
20190219573
2019-07-18

Biomarker signatures and uses thereof

#1971
20190219572
2019-07-18

Signal amplification in lateral flow and related immunoassays

#1972
20190218587
2019-07-18

Screening method for candidate substances for active component to prevent or treat at least one disease selected from the group consisting of renal hypofunction, chronic kidney disease and kidney failure

#1973
20190218286
2019-07-18

Compositions and methods for measuring NMU and for treatment using anti-NMU agents

#1974
20190211400
2019-07-11

METHODS OF USING SINGLE NUCLEOTIDE POLYMORPHISMS IN THE TL1A GENE TO PREDICT OR DIAGNOSE INFLAMMATORY BOWEL DISEASE

#1975
20190211339
2019-07-11

Modulators of telomere disease

#1976
20190209056
2019-07-11

Method and device for optical detection of Kawasaki disease and treatment result

#1977
20190204343
2019-07-04

DIAGNOSTIC METHOD FOR MULTIPLE SCLEROSIS

#1978
20190204342
2019-07-04

METHODS AND USES OF MITOFUSINS

#1979
20190203259
2019-07-04

Method of monitoring RNase L activity

#1980
20190202915
2019-07-04

Method of altering an antibody-related adverse event based on SCD163 and/or CXCL5 levels

#1981
20190202899
2019-07-04

Dosing algorithm for complement inhibitor

#1982
20190201507
2019-07-04

METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF COMPLEX REGIONAL PAIN SYNDROME

#1983
20190198170
2019-06-27

Method for predicting severity and prognosis of cardiovascular disease

#1984
20190195897
2019-06-27

GLYCOSYLATED METABOLITES

#1985
20190195895
2019-06-27

Diagnosis and anti-Mullerian hormone (AMH) administration for treatment of infertility for good-, intermediate- and poor-prognosis patients for in vitro fertilization in view of logistic regression models

#1986
20190195891
2019-06-27

DIAGNOSTIC AND THERAPEUTIC USES OF EXOSOMES

#1987
20190195890
2019-06-27

Procedure of predicting type 2 diabetes development through analysis of N-glycans attached to the plasma proteins of a healthy person

#1988
20190195888
2019-06-27

Identification and monitoring of cleaved immunoglobulins by molecular mass

#1989
20190195862
2019-06-27

Methods for identifying and treating cachexia or pre-cachexia using an inhibitor of rage

#1990
20190194749
2019-06-27

METHOD FOR OBTAINING USEFUL DATA FOR THE DIFFERENTIAL DIAGNOSIS OF LIVER FIBROSIS

#1991
20190194725
2019-06-27

Method for detecting active tuberculosis

#1992
20190194275
2019-06-27

MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications

#1993
20190192652
2019-06-27

Peanut formulations and used thereof

#1994
20190187157
2019-06-20

Qualitative predictive method for differential diagnosis of pneumococcal, meningococcal and viral meningitis, method and kit for differential diagnosis of meningitis

#1995
20190187154
2019-06-20

BIOMEDICAL MEASURING DEVICES, SYSTEMS, AND METHODS FOR MEASURING PEPTIDE CONCENTRATION TO MONITOR A CONDITION

#1996
20190183991
2019-06-20

METHOD OF PREVENTING ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA ASSOCIATED WITH C1 ESTERASE INHIBITOR DEFICIENCY

#1997
20190178897
2019-06-13

HISTONES AND/OR PROADM AS MARKERS INDICATING ORGAN DYSFUNCTION

#1998
20190178896
2019-06-13

MARKER FOR THE CLASSIFICATION, DIAGNOSIS AND TREATMENT OF SCOLIOSIS

#1999
20190178895
2019-06-13

Methods and algorithms for aiding in the detection of cancer

#2000
20190178890
2019-06-13

Antibody to cytolethal distending toxin of Campylobacter jejuni

#2001
20190177403
2019-06-13

Method of treating extracellular tissue and vascular calcification and arteriosclerosis

#2002
20190175723
2019-06-13

Peanut formulations and uses thereof

#2003
20190175700
2019-06-13

Therapeutic intervention for osteoporosis

#2004
20190170770
2019-06-06

Diagnostic Test to Exclude Significant Renal Injury

#2005
20190170769
2019-06-06

METHODS AND COMPOSITIONS FOR DETECTING ENDOMETRIAL OR OVARIAN CANCER

#2006
20190169313
2019-06-06

Monoclonal antibody specific for gamma-glutamyl-l-epsilon-lysine for the monitoring of apoptosis

#2007
20190162737
2019-05-30

CIRCULATING ESM-1 (ENDOCAN) IN THE ASSESSMENT OF ATRIAL FIBRILLATION AND/OR STROKE

#2008
20190162736
2019-05-30

Methods and kits for diagnosing postoperative pulmonary infections in patients who underwent surgery

#2009
20190161535
2019-05-30

COMPOSITIONS AND METHODS FOR TREATING SPINAL MUSCULAR ATROPHY

#2010
20190154706
2019-05-23

Marker for statin treatment stratification in heart failure

#2011
20190154705
2019-05-23

ONE STEP CARDIAC TEST DEVICE

#2012
20190154704
2019-05-23

DETECTING SEPSIS

#2013
20190154662
2019-05-23

Method of drug design and optimisation utilizing stereochemical mimicry

#2014
20190153035
2019-05-23

PEPTIDE INHIBITORS OF CALCIUM OXALATE MONOHYDRATE CRYSTALLIZATION AND USES THEREOF

#2015
20190151406
2019-05-23

Lipopeptides for use in treating liver diseases and cardiovascular diseases

#2016
20190147982
2019-05-16

COMPOSITIONS AND METHODS RELATED TO OBSTRUCTIVE SLEEP APNEA

#2017
20190145987
2019-05-16

Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells

#2018
20190145984
2019-05-16

Thyroglobulin quantitation by mass spectroscopy

#2019
20190145981
2019-05-16

METHODS FOR DETERMINING DPP3 AND THERAPEUTIC METHODS

#2020
20190144945
2019-05-16

Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy

#2021
20190142832
2019-05-16

Marker for Cancer Prognosis and Methods Related Thereto

#2022
20190137514
2019-05-09

COMPEPTIDE AND ANTIBODIES THERETO FOR DIAGNOSING OSTEOARTHRITIS

#2023
20190137513
2019-05-09

PROTEIN ACTIVITY MODIFICATION

#2024
20190137505
2019-05-09

BIOMARKERS OF METHYLGLYOXAL AND RELATED METHODS THEREOF

#2025
20190137502
2019-05-09

Measurement of glycoprotein

#2026
20190137485
2019-05-09

ZNT8 assays for drug development and pharmaceutical compositions

#2027
20190136185
2019-05-09

REGULATORY B CELLS AND THEIR USES

#2028
20190134077
2019-05-09

PROCESS FOR THE IDENTIFICATION OF COMPOUNDS FOR TREATING CANCER

#2029
20190134020
2019-05-09

C5aR INHIBITOR REDUCTION OF URINARY sCD163

#2030
20190133517
2019-05-09

Free radical consumption speed information acquisition method and NASH determination method

#2031
20190128900
2019-05-02

Methods and kits for the diagnosis and risk stratification of patients with ischemia

#2032
20190128878
2019-05-02

Methods for categorizing and treating subjects at risk for pulmonary exacerbation and disease progression

#2033
20190127804
2019-05-02

Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer

#2034
20190120858
2019-04-25

METHODS FOR EVALUATING RENAL INJURY AND RENAL FAILURE USING URINE LEVELS OF CHITINASE-3-LIKE PROTEIN 1

#2035
20190120857
2019-04-25

Ensemble-decision aliquot ranking

#2036
20190120856
2019-04-25

Detection of symmetrical dimethylarginine

#2037
20190120855
2019-04-25

Biomarkers for Fatty Liver Disease and Methods Using the Same

#2038
20190120854
2019-04-25

Method of treating asthma using an IL-13 antibody

#2039
20190120853
2019-04-25

METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS

#2040
20190120852
2019-04-25

DIAGNOSIS OF CARDIOVASCULAR DISEASE

#2041
20190120837
2019-04-25

Protein signatures for distinguishing between bacterial and viral infections

#2042
20190117685
2019-04-25

PROCESS FOR THE IDENTIFICATION OF COMPOUNDS FOR TREATING CANCER

#2043
20190117664
2019-04-25

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES

#2044
20190113530
2019-04-18

Biomarker for the diagnosis of pulmonary hypertension (PH)

#2045
20190113526
2019-04-18

Biomarkers for diagnosing post traumatic stress disorder

#2046
20190113525
2019-04-18

METHOD OF DETERMINING AUTOPHAGOSOME FLUX AND USES THEREOF

#2047
20190113524
2019-04-18

METHOD FOR DETERMINING MORBIDITY TO DIABETES

#2048
20190112660
2019-04-18

Identification of unique blood-based gene expression profiles in children with regressive autism spectrum disorder (ASD) and ileocolitis

#2049
20190112582
2019-04-18

In vitro method for identifying thoracic aortic aneurysms (TAA) in a subject

#2050
20190112363
2019-04-18

Polypeptides and polypeptide constructs comprising single domain antibodies directed against von willebrand factor

#2051
20190112352
2019-04-18

TGF-receptor II isoform, fusion peptide, methods of treatment and methods in vitro

#2052
20190107546
2019-04-11

Method for Identifying an Agent for Treating Abnormal Kidney Function

#2053
20190107545
2019-04-11

Methods for detecting, diagnosing and treating ulcerative interstitial cystitis

#2054
20190107530
2019-04-11

METHOD OF DETECTION OF CLINICALLY SIGNIFICANT POST-PRANDIAL HYPERGLYCEMIA IN NORMOGLYCEMIC PATIENTS

#2055
20190106750
2019-04-11

Biomarkers for use in prognosis of mortality in critically ill patients

#2056
20190106496
2019-04-11

Methods Of Identifying Anti-Inflammatory Compounds

#2057
20190106493
2019-04-11

Immunological reagents

#2058
20190101550
2019-04-04

Ceramides for evaluating risk of cardiovascular disease

#2059
20190099429
2019-04-04

CENICRIVIROC FOR THE TREATMENT OF FIBROSIS

#2060
20190094244
2019-03-28

Free Functional Annexin Levels in Plasma as a Biomarker of Cardiovascular Risk

#2061
20190094243
2019-03-28

Method of diagnosing arthritis or other joint degrading disease

#2062
20190094239
2019-03-28

MASS SPECTROMETRY KIT

#2063
20190094229
2019-03-28

METHODS OF DIAGNOSING, CLASSIFYING AND TREATING ENDOMETRIAL CANCER AND PRECANCER

#2064
20190093144
2019-03-28

TISSUE TESTER

#2065
20190092857
2019-03-28

Method of modulating the adrenomedullin (ADM) activity of a patient by administering to the patient an anti-ADM antibody or fragment thereof that specifically binds to mature human ADM

#2066
20190092844
2019-03-28

Method for diagnosis of polycystic ovary syndrome (PCOS) by measuring levels of DENN/MADD domain containing 1A variant 2 (DENND1A variant 2)

#2067
20190091292
2019-03-28

COMPOSITION FOR DIAGNOSING ALLERGIES TO MITES, METHOD OF DIAGNOSING ALLERGIES TO MITES, AND COMPOSITION FOR PREVENTING OR TREATING ALLERGIES TO MITES

#2068
20190086427
2019-03-21

Method of testing for pulmonary hypertension

#2069
20190086426
2019-03-21

Secreted P-glycoprotein is a non-invasive biomarker of chronic rhinosinusitis

#2070
20190086425
2019-03-21

Diagnostic for sjorgen's syndrome based on a biomarker

#2071
20190086409
2019-03-21

MEDICAL APPARATUS FOR TESTING FOR MEDICAL CONDITIONS INCLUDING ZIKA, PREGNANCY, AND THE TORCH COMPLEX

#2072
20190086408
2019-03-21

MEDICAL APPARATUS FOR TESTING FOR MEDICAL CONDITIONS INCLUDING PREGNANCY AND THE TORCH COMPLEX

#2073
20190086407
2019-03-21

Medical apparatus for testing for medical conditions including zika and pregnancy

#2074
20190085065
2019-03-21

Agents for use in the therapeutic treatment of hyperopia

#2075
20190083973
2019-03-21

Assay device measuring viscosity and detecting or measuring a biomaker

#2076
20190079104
2019-03-14

DIAGNOSTIC METHOD FOR URINARY TRACT INFECTION

#2077
20190079103
2019-03-14

METHOD FOR CHARACTERIZATION OF CELL SPECIFIC MICROVESICLES

#2078
20190079102
2019-03-14

Methods and kits

#2079
20190079082
2019-03-14

Calcium binding protein, spermatid specific 1, as a biomarker for diagnosis or treatment of stress

#2080
20190078163
2019-03-14

Compositions and methods for diagnosing and monitoring hyperthyroidism in a feline

#2081
20190078074
2019-03-14

OBESITY RISK DIAGNOSIS KIT AND METHOD FOR ANALYZING RISK OF OBESITY ONSET

#2082
20190076502
2019-03-14

Medical use of CREG protein

#2083
20190072568
2019-03-07

DIAGONSIS AND TREATMENT OF AUTOIMMUNE DISEASES BY TARGETING AUTOIMMUNE-RELATED B CELLS ("ABCS")

#2084
20190072567
2019-03-07

METHOD OF DETECTING LC3B EXPRESSION IN EXOSOMES EXTRACTED FROM LIQUID BIOLOGICAL SAMPLES

#2085
20190072551
2019-03-07

CNS Antigen-Specific B Cell and Antibody Assays in Multiple Sclerosis

#2086
20190071795
2019-03-07

METHODS AND SYSTEMS FOR DETECTING TISSUE CONDITIONS

#2087
20190071728
2019-03-07

Compositions and methods for diagnosing and monitoring hyperthyroidism in a feline

#2088
20190071707
2019-03-07

NMR methods and systems for the rapid detection of bacteria

#2089
20190070144
2019-03-07

Treatment of circadian rhythm disorders

#2090
20190064186
2019-02-28

Biomarkers for Cell Therapy

#2091
20190064185
2019-02-28

METHODS OF DETECTING AND TREATING AIRWAY INFLAMMATORY DISEASES

#2092
20190064183
2019-02-28

Method for detecting nucleosomes containing histone modifications and variants

#2093
20190064181
2019-02-28

IL-22BP AS BIOMARKER IN ANTI-TNF-ALPHA-TREATMENTS

#2094
20190064166
2019-02-28

Methods of treating volume depletion and kidney injury

#2095
20190064102
2019-02-28

SYSTEMS AND METHODS FOR THE DETECTION OF GLYPICAN-1

#2096
20190062837
2019-02-28

Screening method

#2097
20190062836
2019-02-28

METHODS OF PROGNOSING, DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS

#2098
20190062722
2019-02-28

Methods and compounds for reducing threonyl-tRNA synthetase activity

#2099
20190062431
2019-02-28

Immunological reagents

#2100
20190062425
2019-02-28

TM4SF1 binding proteins and methods of using same